CORD-19:ee0a7632371a08727d41e55aad7d621daeceef7d / 44136-44355 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/ee0a7632371a08727d41e55aad7d621daeceef7d","sourcedb":"CORD-19","sourceid":"ee0a7632371a08727d41e55aad7d621daeceef7d","text":"BabyGenes, Inc, in partnership with ArcherDX, Inc., has developed a targeted next-generation sequencing (NGS) assay based on Anchored Multiplex PCR (AMP) to detect all mutations currently reported in the CFTR2 database.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T417","span":{"begin":0,"end":219},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T417","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T417","span":{"begin":0,"end":219},"obj":"Sentence"}],"attributes":[{"subj":"T417","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ec93b5","default":true},{"id":"CORD-19_Custom_license_subset","color":"#93cfec"}]}]}}